Shattuck Labs, Inc. Common Stock STTK
$7.66
+2.82%
at last close
Analyst Consensus
- Consensus Rating
- Buy (8 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $14.43
- Implied Upside
- +88.4%
- Price Target Range
- $10.00 – $18.00
- Analysts (12 mo)
- 8
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-11 | HC Wainwright & Co.Joseph Pantginis |
Maintains | Buy | $18 → $14 |
| 2026-07-24 | JP MorganBrian Cheng |
Initiates coverage on | Overweight | $10 |
| 2026-07-20 | Leerink PartnersFaisal Khurshid |
Initiates coverage on | Outperform | $16 |
| 2026-06-09 | CitigroupYigal Nochomovitz |
Maintains | Buy | $7 → $18 |
| 2026-06-08 | NeedhamJoseph Stringer |
Maintains | Buy | $14 → $17 |
| 2026-06-08 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $18 |
| 2026-06-05 | CitigroupYigal Nochomovitz |
Upgrades | Neutral → Buy | $7 |
| 2026-05-08 | WedbushDavid Nierengarten |
Maintains | Outperform | $8 → $11 |
| 2026-04-27 | Cantor FitzgeraldPrakhar Agrawal |
Initiates coverage on | Overweight | — |
| 2026-04-20 | HC Wainwright & Co.Joseph Pantginis |
Maintains | Buy | $6 → $18 |
| 2026-03-13 | CitigroupYigal Nochomovitz |
Maintains | Neutral | $4 → $7 |
| 2026-03-06 | WedbushDavid Nierengarten |
Maintains | Outperform | $4 → $8 |
| 2026-01-28 | Piper SandlerYasmeen Rahimi |
Initiates coverage on | Overweight | $15 |
| 2026-01-06 | CitigroupYigal Nochomovitz |
Maintains | Neutral | $2 → $4 |
| 2025-12-01 | HC Wainwright & Co.Joseph Pantginis |
Upgrades | Neutral → Buy | $6 |
| 2025-09-08 | WedbushDavid Nierengarten |
Initiates coverage on | Outperform | $4 |
| 2025-08-14 | Leerink PartnersFaisal Khurshid |
Maintains | Outperform | $4 → $2 |
| 2025-08-14 | NeedhamJames Ricchiuti |
Reiterates | Hold | — |
| 2025-03-27 | NeedhamGil Blum |
Reiterates | Hold | — |
| 2025-03-27 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Neutral | — |
| 2025-03-17 | Leerink PartnersFaisal Khurshid |
Initiates coverage on | Outperform | $4 |
| 2024-11-15 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Neutral | — |
| 2024-11-14 | NeedhamGil Blum |
Reiterates | Hold | — |
| 2024-10-02 | CitigroupYigal Nochomovitz |
Downgrades | Buy → Neutral | $8 → $2 |
| 2024-10-02 | NeedhamGil Blum |
Downgrades | Buy → Hold | $8 |
| 2024-10-01 | HC Wainwright & Co.Joseph Pantginis |
Downgrades | Buy → Neutral | — |
| 2024-08-27 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $16 |
| 2024-08-15 | CitigroupYigal Nochomovitz |
Maintains | Buy | $9 → $8 |
| 2024-08-02 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $16 |
| 2024-08-02 | NeedhamGil Blum |
Reiterates | Buy | $8 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $7.66
- Market Cap
- $747.71 million
- 52-Week Range
- $0.71 – $8.33
- Average Volume
- 1.14 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.